openPR Logo
Press release

Wilson’s Disease Treatment Market – Global Industry Insights, Trends and Opportunity Analysis, 2017–2025

06-26-2017 04:41 PM CET | Health & Medicine

Press release from: CMI - Pharmaceutical Research

Wilson’s Disease Treatment Market – Global Industry

Wilson's disease is characterized by a disproportionate amount of copper in the body. The disease is genetic and it is a rare autosomal recessive disorder, with copper build up in the liver and the brain. If not diagnosed early, Wilson’s disease can be fatal. Symptoms include weakness, vomiting, tremors, anxiety, and personality changes. The primary reason for the disease is mutation in ATP7B or Wilson disease protein. Treatment of Wilson’s disease includes medication as well as dietary changes. Dietary changes include food with low copper content and avoidance of copper utensils. The complications of Wilson’s disease include cirrhosis, liver cancer, kidney damage, liver failure, nervous system problems, and in some extreme cases, death.

Wilson’s disease may lead to Kayser-Fleischer rings, which results from the deposition of copper in the eyes. People with Wilson’s disease with signs of nervous system disorder generally have Kayser-Fleischer rings. Nevertheless, the rings are estimated to be present in 40 to 66 percent of people who shows signs of liver damage only, according to National Center for Biotechnology Information (NCBI). Wilson’s disease is believed to affect one in 30,000 people. The disease occurs equally in men and women. Early detection is crucial to effective treatment.

Click here to Download Sample report copy:

As the population is rising at an alarming rate, the probability of occurrence of the disease increases proportionately, since Wilson’s disease is genetic. This in turn, is expected to fuel growth of the Wilson’s disease treatment market.

Wilson’s disease Treatment Taxonomy

On the basis of type of treatment, global Wilson’s disease treatment market is classified into:

Liver Transplant

On the basis of type of end user, the global Wilson’s disease treatment market is classified into:

Medical Practitioners

Browse report summery with TOC:

Owing to advancements in medical sciences and initiatives by regulatory bodies such as National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and Wilson’s Disease Association (WDA), the treatment options as well as awareness about Wilson’s disease treatment has increased substantially in the recent past. Although, signs and symptoms of the disease usually do not appear till 6 years of age, new cases of the disease have been reported from other age groups as well.

Rising population and early detection to drive the overall Wilson’s disease treatment market

Asia Pacific is poised to offer a lucrative opportunity for the growth of the Wilson’s disease treatment market. This is due to rise in population in the region, especially in countries such as China, and India, as well as increasing awareness and growth in the overall expenditure on healthcare. According to a research report titled ‘Wilson’s disease in Asia’, authored by Yue Zhang, Zhi-Ying Wu, the occurrence of Wilson’s disease in Asia may be higher than that of other parts of the world. According to Chu NS and Hung TP’s report titled ‘Geographic variations in Wilson's disease’, the incidence of Wilson’s disease varied from 12 to 29 per 100,000 in European population. However, according to Arima M, and Sano I’s report titled ‘Genetic studies of Wilson's disease in Japan’, the commonness in Asian countries excluding India varied from 33 to 68 per 100,000, which is substantially higher than that of the European population. Asia constitutes 60% of the world's current population. As the disease is hereditary, the chances of occurrence of Wilson’s disease in the future are much higher in the region; hence the growth potential of Wilson’s disease treatment market is fairly high in Asia. This in turn will help in the expansion of the overall Wilson’s disease treatment market during the forecast period.

Some of the medications used in Wilson’s disease treatment are chelating agents such as trientine and d-penicillamine, and zinc, in addition to dietary modifications. Some of the companies operating in the market are SGPharma Pvt. Ltd., Valeant Pharmaceuticals, tsumura & Co., Merck & Co., VHB Life Science Inc. (Cardion), and Teva Pharmaceuticals USA, Inc.

Get More Details About This Report @

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Tel: +1-206-701-6702

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Wilson’s Disease Treatment Market – Global Industry Insights, Trends and Opportunity Analysis, 2017–2025 here

News-ID: 595675 • Views: 279

More Releases from CMI - Pharmaceutical Research

Global Pulmonary Arterial Hypertension (PAH) Market - Pfizer, Inc., Actelion Pharmaceuticals, Ltd., Gilead Sciences, Inc.
Global Pulmonary Arterial Hypertension (PAH) Market - Pfizer, Inc., Actelion Pha …
Pulmonary hypertension or PH is a condition in which the blood pressure rises in the pulmonary artery, vein, or capillaries (collectively known as lung vasculature), which might lead to shortness of breath, fainting, leg swelling, and dizziness, among others. Pulmonary hypertension may be a relentless disease with a noticeable reduction in exercise tolerance. Pulmonary arterial hypertension or PAH indicates that the patient has high blood pressure in arteries that carry
Betaxolol Market - Size, Share, Growth, Outlook, and Trends Analysis 2018–2026
Betaxolol Market - Size, Share, Growth, Outlook, and Trends Analysis 2018–2026
Betaxolol is a racemic mixture and beta-adrenergic receptor inhibitor used to treat patients with chronic open-angle glaucoma or ocular hypertension. It was first approved by the U.S. Food and Drug Administration (FDA) in 1989, as an oral tablet. Betaxolol is used either alone or in combination with other medicines to lower down the pressure within the heart or eye. In the heart, Betaxolol decreases the cardiac contractility and rate selectively
Gene Therapy Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
Gene Therapy Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
Genes are composed of deoxyribonucleic acid (DNA), which contains essential information for producing proteins that are crucial for the optimal functioning of the body. Genetic disorder is the result of gene mutations in which proteins are made incorrectly. Gene therapy is intended to introduce healthy gene into damaged cells to counteract for abnormal genes or to make a protein of interest. Mutated gene causes missing of the important protein, with
Cervical Cancer Drugs Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
Cervical Cancer Drugs Market - Size, Share, Outlook, and Opportunity Analysis, 2 …
Cervical cancer develops in women’s cervix, and mainly affects sexually active women aged between 30 and 45. Cervical cancer often shows no symptoms in early stages. However, the death rate of cervical cancer can be significantly reduced with use of Pap test (Papanicolaou test): a screening procedure which can detect the changes in the cervix before the cancer develops. There are different types of cervical cancer, out of which two

All 5 Releases

More Releases for Wilson

Corporate Training Services Market Is Booming Worldwide | Wilson Learning Worldw …
Corporate Training Services Market: The extensive research on Corporate Training Services Market, by Qurate Research is a clear representation on all the essential factors that are expected to drive the market considerably. Thorough study on Corporate Training Services Market helps the buyers of the report, customers, the stakeholders, business owners, and stockholders to understand the market in detail. The updated research report comprises key information on the market, such as
Tennis Racquet Strings Market Wilson, Babolat, HEAD
UpMarketResearch offers a latest published report on Global Tennis Racquet Strings Market industry analysis and forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains XX pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Tennis Racquet Strings Market research report delivers a close watch on leading competitors with strategic analysis,
Wilson Disease Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Wilson Disease - Pipeline Review, H1 2017, provides an overview of the Wilson Disease (Genetic Disorders) pipeline landscape. Wilson disease is a rare autosomal recessive inherited disorder of copper metabolism that is characterized by excessive deposition of copper in the liver, brain, and other tissues. Symptoms include abdominal pain, jaundice, problems with speech, swallowing and muscle stiffness. Treatment includes chelators and Vitamin E
Wilson Realty is now Wilson & Associates Real Estate and Property Management
PRESS RELEASE Contact: Linda J. Wilson, Broker Phone: 727-398-5700 WILSON REALTY IS NOW WILSON & ASSOCIATES REAL ESTATE AND PROPERTY MANAGEMENT North Redington Beach, FL November 6, 2017 – Linda J. Wilson, Broker/Owner of Wilson Realty announced this week that the company has officially changed its name to Wilson & Associates Real Estate and Property Management as of November 1, 2017. Linda Wilson, Broker/Owner explained that the new name reflects the evolving focus
Tennis Apparel and Footwear 2017 Global Market by Types, Countries, Manufacturer …
Tennis Apparel and Footwear Market 2017 Report Details: Wiseguyreports.Com Adds “Tennis Apparel and Footwear Market - Market Size, Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2022” To Its Research Database. Global Tennis Apparel and Footwear market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including NIKE Adidas Wilson HEAD LiNing Prince Champion Yonex Kappa Babolat Dunlop Flia Decathlon
Global Volleyball Market- Train, Under Armour, Tachikara, Wilson
Global Volleyball Market report 2017 is an in-depth research on the current situation of the Volleyball industry. The Scope of the Volleyball research report: The Global Volleyball Market primarily includes a basic overview of the Volleyball industry. It also includes Volleyball definitions, classifications and applications. It segments the market by applications, types, regions, competitive players and also analyzes Volleyball market size, business share and Volleyball revenue, price and sales. The report mainly